Sarepta Therapeutics Inc (SRPT)
121.90
+1.24
(+1.03%)
USD |
NASDAQ |
Dec 24, 16:00
Sarepta Therapeutics Cash and Short Term Investments (Quarterly): 1.198B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Arrowhead Pharmaceuticals Inc | 680.96M |
Eli Lilly and Co | 3.518B |
Alnylam Pharmaceuticals Inc | 2.780B |
Catalyst Pharmaceuticals Inc | 442.33M |
Vertex Pharmaceuticals Inc | 6.524B |